5 Results for "

AZD-5363

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "AZD-5363" in MCE Product Catalog:

89
89 Cited Publications
Cat. No.: HY-15431
CAS No.: 1143532-39-1
Purity:  99.95%
Synonyms: AZD5363
Target:  

Akt Autophagy

Research Areas:  

Cancer

Capivasertib (AZD5363) is an orally active and potent pan-AKT kinase inhibitor with IC50 of 3, 7 and 7 nM for Akt1,Akt2 and Akt3, respectively.
loading...
    loading...
Cat. No.: HY-15431A
CAS No.: 1143532-51-7
Synonyms: (R)-AZD5363
Target:  

Akt

Research Areas:  

Cancer

(R)-Capivasertib ((R)-AZD5363) is the R-enantiomer of Capivasertib (HY-15431) .
loading...
    loading...
Cat. No.: HY-15431R
CAS No.: 1143532-39-1
Synonyms: AZD5363 (Standard)
Research Areas:  

Cancer

Capivasertib (Standard) is the analytical standard of Capivasertib. This product is intended for research and analytical applications. Capivasertib (AZD5363) is an orally active and potent pan-AKT kinase inhibitor with IC50 of 3, 7 and 7 nM for Akt1,Akt2 and Akt3, respectively.
loading...
    loading...
Cat. No.: HY-15431S
Synonyms: AZD5363-d4
Capivasertib-d4 (AZd5363-d4) is the deuterium labeled Capivasertib (HY-15431). Capivasertib (AZD5363) is an orally active and potent pan-AKT kinase inhibitor with IC50 of 3, 7 and 7 nM for Akt1,Akt2 and Akt3, respectively.
loading...
    loading...
Cat. No.: HY-100038
CAS No.: 1905412-80-7
Target:  

IGF-1R Insulin Receptor

Research Areas:  

Cancer

AZD9362 is a reversible, ATP-competitive and orally active small molecule inhibitor of IGF-1R and insulin receptor. AZD9362 inhibits the IGF-1R enzyme with an IC50 of 14 nM. AZD9362 can enhance the anti-tumor effect of AZD5363 (HY-15431). AZD9362 can be used for the research of cancer, such as breast cancer .
loading...
    loading...